Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders.
In neonatal mice ultrasonic vocalizations have been studied both as an early communicative behaviour of the pup-mother dyad and as a sign of an aversive affective state. Adult mice of both sexes produce complex ultrasonic vocalization patterns in different experimental/social contexts. Vocalizations are becoming an increasingly valuable assay for behavioural phenotyping throughout the mouse life-span and alterations of the ultrasound patterns have been reported in several mouse models of neurodevelopmental disorders. Here we also show that the modulation of vocalizations by maternal cues (maternal potentiation paradigm) - originally identified and investigated in rats - can be measured in C57BL/6 mouse pups with appropriate modifications of the rat protocol and can likely be applied to mouse behavioural phenotyping. In addition we suggest that a detailed qualitative evaluation of neonatal calls together with analysis of adult mouse vocalization patterns in both sexes in social settings, may lead to a greater understanding of the communication value of vocalizations in mice. Importantly, both neonatal and adult USV altered patterns can be determined during the behavioural phenotyping of mouse models of human neurodevelopmental and neuropsychiatric disorders, starting from those in which deficits in communication are a primary symptom.
Scattoni
Maria Luisa
ML
Section of Neurotoxicology and Neuroendocrinology, Department of Cell Biology, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Rome, Italy.
Crawley
Jacqueline
J
Ricceri
Laura
L
D000818:Animals; D000831:Animals, Newborn; D002648:Child; D002658:Developmental Disabilities; D004195:Disease Models, Animal; D006801:Humans; D008426:Maternal Deprivation; D051379:Mice; D009422:Nervous System Diseases; D018377:Neurotransmitter Agents / Q000378:metabolism; D010641:Phenotype; D012919:Social Behavior; D014465:Ultrasonics; D014828:Vocalization, Animal / Q000502:physiology*
D018377:Neurotransmitter Agents
Eur J Pharmacol. 1993 Mar 16;233(1):101-7
8472738
Behav Brain Res. 2001 Nov 1;125(1-2):49-56
11682093
Behav Genet. 1996 Jul;26(4):427-37
8771903
Behav Genet. 2005 Jan;35(1):93-102
15674536
Dev Psychobiol. 2003 Sep;43(2):90-101
12918088
Physiol Behav. 1983 Sep;31(3):269-72
6634993
Behav Neurosci. 1996 Oct;110(5):1158-67
8919018
Eur J Pharmacol. 1996 Oct 10;313(1-2):43-9
8905327
Psychol Rev. 2001 Jan;108(1):83-95
11212634
Behav Processes. 1995 Mar;33(3):257-71
24896999
Dev Psychobiol. 1994 Mar;27(2):101-10
8187967
Psychopharmacology (Berl). 2006 Aug;187(3):331-44
16783542
J Comp Psychol. 1998 Dec;112(4):331-43
9861709
Behav Brain Res. 2007 Sep 4;182(2):223-30
17336405
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7652-7
17442747
Behav Genet. 2005 Jan;35(1):103-12
15674537
Psychoneuroendocrinology. 1996 Feb;21(2):203-17
8774063
Behav Brain Res. 2004 May 5;151(1-2):9-16
15084416
Dev Psychobiol. 1982 May;15(3):221-7
7095288
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16096-101
16249339
Behav Brain Res. 2008 Mar 5;187(2):371-8
18005969
Genes Brain Behav. 2002 Aug;1(3):135-41
12884969
Neuropeptides. 2002 Apr-Jun;36(2-3):221-9
12359512
Behav Genet. 2005 Jan;35(1):73-83
15674534
Behav Brain Res. 2007 Sep 4;182(2):180-92
17379325
PLoS One. 2007 Apr 04;2(4):e351
17406675
Cereb Cortex. 2005 Dec;15(12):2013-20
15788701
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9643-8
15983371
Trends Pharmacol Sci. 2003 Nov;24(11):580-8
14607081
PLoS Biol. 2005 Dec;3(12):e386
16248680
Dev Psychobiol. 1994 Jul;27(5):301-16
7926282
Genes Brain Behav. 2008 Apr;7(3):344-54
17908176
Neurosci Biobehav Rev. 1998 May;22(3):437-52
9579331
J Pharmacol Exp Ther. 2006 Dec;319(3):1317-26
16990508
Brain Res Brain Res Rev. 1998 Mar;26(1):29-42
9600623
Behav Pharmacol. 1991 Apr;2(2):121-128
11224056
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1912-7
11172050
J Comp Psychol. 1985 Dec;99(4):420-36
4075780
Behav Brain Res. 2007 Jan 10;176(1):40-52
16996147
Behav Genet. 1995 Jan;25(1):75-80
7755521
J Neurosci. 2005 Dec 14;25(50):11521-30
16354910
J Comp Psychol. 2002 Sep;116(3):286-96
12234079
Mol Psychiatry. 2008 Jan;13(1):4-26
17848915
Behav Biol. 1974 Sep;12(1):55-66
4429513
Behav Brain Res. 2006 Mar 15;168(1):56-63
16310869
Anim Behav. 2000 Nov;60(5):689-694
11082239
Behav Brain Res. 2007 Feb 12;177(1):142-9
17141885
Behav Pharmacol. 2005 Sep;16(5-6):431-40
16148448
Dev Psychobiol. 1980 Nov;13(6):573-84
7429018
J Comp Psychol. 2004 Mar;118(1):95-102
15008677
PLoS Biol. 2007 Jul;5(7):e173
17564499
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13333-8
8917591
Dev Psychobiol. 1986 Jul;19(4):385-98
3732628
J Comp Psychol. 2002 Sep;116(3):297-307
12234080
Physiol Behav. 1985 Aug;35(2):167-74
4070379
Eur J Pharmacol. 1991 Oct 2;203(1):149-52
1665788
Dev Psychobiol. 2001 Mar;38(2):92-100
11223801
Nature. 1970 Jul 25;227(5256):410
5464098
Physiol Behav. 2005 Jan 17;83(5):767-77
15639162
Behav Neural Biol. 1982 Oct;36(2):197-203
7183314
Dev Psychobiol. 2002 Mar;40(2):147-59
11857329
Brain Res Dev Brain Res. 1991 Sep 19;62(1):17-22
1662121
Dev Psychobiol. 2003 Mar;42(2):194-205
12555283
Dev Psychobiol. 1972;5(4):371-87
4609822
Pharmacol Biochem Behav. 2007 Mar;86(3):431-40
17291571
Science. 2004 Jun 25;304(5679):1983-6
15218152
Behav Neurosci. 1997 Jun;111(3):599-605
9189274
Behav Brain Res. 2007 Oct 1;183(1):111-7
17624452
Anim Behav. 1966 Oct;14(4):459-62
5972804
J Neurosci. 2007 Oct 3;27(40):10912-7
17913925
Neuropharmacology. 2000 Jun 8;39(8):1413-21
10818257
Eur J Neurosci. 2006 Jun;23(11):3087-97
16819999
PLoS One. 2008 Apr 02;3(4):e1893
18382674
Neuropediatrics. 1999 Jun;30(3):125-9
10480206
Behav Neurosci. 1999 Jun;113(3):587-601
10443785
Nat Rev Neurosci. 2005 Feb;6(2):131-8
15685218
Dev Psychobiol. 1998 Nov;33(3):249-56
9810475
Behav Neurosci. 1990 Oct;104(5):808-17
2244987
Physiol Behav. 1996 Jul;60(1):299-304
8804680
Dev Psychobiol. 2006 Dec;48(8):653-9
17111400
Neuroreport. 2006 Apr 3;17(5):541-4
16543822
Horm Behav. 2000 Mar;37(2):145-55
10753584